U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 1249

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:12774517
GRCh38:
Chr19:12663703
MAN2B1G255RDeficiency of alpha-mannosidaseUncertain significance
(Jun 22, 2021)
criteria provided, single submitter
2.
GRCh37:
Chr19:12760717-12761046
MAN2B1Deficiency of alpha-mannosidaseLikely pathogenic
(Sep 13, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr19:12760707-12763294
MAN2B1Deficiency of alpha-mannosidaseLikely pathogenic
(Dec 30, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr19:12757424-12769334
MAN2B1Deficiency of alpha-mannosidasePathogenic
(Jul 4, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr19:12774121-12774659
MAN2B1Deficiency of alpha-mannosidasePathogenic
(Jun 22, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr19:12757434-12761056
MAN2B1Deficiency of alpha-mannosidasePathogenic
(Feb 20, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr19:12775596-12777525
MAN2B1Deficiency of alpha-mannosidasePathogenic
(Jun 27, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr19:12768857-12780217
WDR83, WDR83OS, MAN2B1Deficiency of alpha-mannosidasePathogenic
(Apr 4, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr19:12757434-12780217
MAN2B1, WDR83, WDR83OSDeficiency of alpha-mannosidasePathogenic
(Apr 18, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr19:10828919-13482613
Deficiency of alpha-mannosidase, Episodic ataxia type 2, Developmental and epileptic encephalopathy, 42,
Charcot-Marie-Tooth disease dominant intermediate B, Glutaric aciduria, type 1
Uncertain significance
(Aug 6, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr19:12768936
GRCh38:
Chr19:12658122
MAN2B1A416V, A417VDeficiency of alpha-mannosidaseUncertain significance
(Jun 12, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr19:12767873-12767897
GRCh38:
Chr19:12657059-12657083
MAN2B1Deficiency of alpha-mannosidaseLikely pathogenic
(Oct 17, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr19:12776504
GRCh38:
Chr19:12665690
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Aug 6, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr19:12775682
GRCh38:
Chr19:12664868
MAN2B1N185SDeficiency of alpha-mannosidaseUncertain significance
(Jul 5, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr19:12768968
GRCh38:
Chr19:12658154
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Mar 29, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr19:12762992
GRCh38:
Chr19:12652178
MAN2B1R673H, R674HDeficiency of alpha-mannosidaseUncertain significance
(May 7, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr19:12768870
GRCh38:
Chr19:12658056
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Aug 2, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr19:12768369
GRCh38:
Chr19:12657555
MAN2B1N436S, N437SDeficiency of alpha-mannosidaseUncertain significance
(Apr 18, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr19:12757500
GRCh38:
Chr19:12646686
MAN2B1T990fs, T991fsDeficiency of alpha-mannosidasePathogeniccriteria provided, single submitter
20.
GRCh37:
Chr19:12758166
GRCh38:
Chr19:12647352
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Aug 24, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr19:12774269
GRCh38:
Chr19:12663455
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Oct 17, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr19:12766678
GRCh38:
Chr19:12655864
MAN2B1S553G, S554GInborn genetic diseases, Deficiency of alpha-mannosidaseUncertain significance
(Nov 23, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr19:12776180
GRCh38:
Chr19:12665366
MAN2B1D141VInborn genetic diseases, Deficiency of alpha-mannosidaseUncertain significance
(Jul 13, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr19:12772088
GRCh38:
Chr19:12661274
MAN2B1Deficiency of alpha-mannosidaseUncertain significance
(Oct 25, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr19:12766653
GRCh38:
Chr19:12655839
MAN2B1P561Q, P562QDeficiency of alpha-mannosidaseUncertain significance
(Jul 8, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr19:12774146
GRCh38:
Chr19:12663332
MAN2B1N298KDeficiency of alpha-mannosidaseUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr19:12772146
GRCh38:
Chr19:12661332
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Oct 17, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr19:12775800
GRCh38:
Chr19:12664986
MAN2B1Deficiency of alpha-mannosidaseLikely pathogenic
(Aug 22, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr19:12777416
GRCh38:
Chr19:12666602
MAN2B1P34TDeficiency of alpha-mannosidaseUncertain significance
(Jul 23, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr19:12761053
GRCh38:
Chr19:12650239
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Oct 17, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr19:12763077
GRCh38:
Chr19:12652263
MAN2B1A645T, A646TDeficiency of alpha-mannosidaseUncertain significance
(Jul 23, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr19:12763268
GRCh38:
Chr19:12652454
MAN2B1R613W, R612WDeficiency of alpha-mannosidaseUncertain significance
(Jul 6, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr19:12769099
GRCh38:
Chr19:12658285
MAN2B1G390A, G389ADeficiency of alpha-mannosidaseUncertain significance
(Aug 15, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr19:12774141
GRCh38:
Chr19:12663327
MAN2B1A300VDeficiency of alpha-mannosidase, Inborn genetic diseasesUncertain significance
(Nov 17, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr19:12767478
GRCh38:
Chr19:12656664
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Sep 22, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr19:12758976
GRCh38:
Chr19:12648162
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Aug 29, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr19:12760201
GRCh38:
Chr19:12649387
MAN2B1P769L, P770LDeficiency of alpha-mannosidaseUncertain significance
(Oct 3, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr19:12776556
GRCh38:
Chr19:12665742
MAN2B1V75LDeficiency of alpha-mannosidaseUncertain significance
(Aug 17, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr19:12774609
GRCh38:
Chr19:12663795
MAN2B1Q224RDeficiency of alpha-mannosidaseUncertain significance
(Jun 15, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr19:12772177
GRCh38:
Chr19:12661363
MAN2B1R308HInborn genetic diseases, Deficiency of alpha-mannosidaseUncertain significance
(Apr 7, 2023)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr19:12761007
GRCh38:
Chr19:12650193
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Sep 3, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr19:12774531
GRCh38:
Chr19:12663717
MAN2B1A250VDeficiency of alpha-mannosidaseUncertain significance
(Oct 25, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr19:12758027
GRCh38:
Chr19:12647213
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Oct 23, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr19:12766591
GRCh38:
Chr19:12655777
MAN2B1V583M, V582MDeficiency of alpha-mannosidaseUncertain significance
(Jun 24, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr19:12767398
GRCh38:
Chr19:12656584
MAN2B1T544I, T543IDeficiency of alpha-mannosidaseUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr19:12767391
GRCh38:
Chr19:12656577
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Apr 1, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr19:12757466
GRCh38:
Chr19:12646652
MAN2B1A1002T, A1001TInborn genetic diseases, Deficiency of alpha-mannosidaseUncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr19:12760813
GRCh38:
Chr19:12649999
MAN2B1K727N, K726NDeficiency of alpha-mannosidaseUncertain significance
(Jun 12, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr19:12759063
GRCh38:
Chr19:12648249
MAN2B1V863I, V864IDeficiency of alpha-mannosidaseUncertain significance
(Aug 9, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr19:12776587
GRCh38:
Chr19:12665773
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Mar 31, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr19:12759074
GRCh38:
Chr19:12648260
MAN2B1A859V, A860VDeficiency of alpha-mannosidaseUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr19:12760006
GRCh38:
Chr19:12649192
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Apr 23, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr19:12774135
GRCh38:
Chr19:12663321
MAN2B1A302VDeficiency of alpha-mannosidaseUncertain significance
(Aug 6, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr19:12769065
GRCh38:
Chr19:12658251
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(May 27, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr19:12776187
GRCh38:
Chr19:12665373
MAN2B1V139MDeficiency of alpha-mannosidaseUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr19:12766567
GRCh38:
Chr19:12655753
MAN2B1R591C, R590CInborn genetic diseases, Deficiency of alpha-mannosidaseUncertain significance
(Feb 14, 2023)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr19:12777508
GRCh38:
Chr19:12666694
MAN2B1A3VDeficiency of alpha-mannosidaseUncertain significance
(Jun 20, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr19:12766539
GRCh38:
Chr19:12655725
MAN2B1S600Y, S599YInborn genetic diseases, Deficiency of alpha-mannosidaseUncertain significance
(Dec 6, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr19:12763007
GRCh38:
Chr19:12652193
MAN2B1P668R, P669RDeficiency of alpha-mannosidaseUncertain significance
(Oct 3, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr19:12775785
GRCh38:
Chr19:12664971
MAN2B1A151TDeficiency of alpha-mannosidaseUncertain significance
(Jun 8, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr19:12767836
GRCh38:
Chr19:12657022
MAN2B1G484V, G485VDeficiency of alpha-mannosidaseUncertain significance
(Jun 8, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr19:12760814
GRCh38:
Chr19:12650000
MAN2B1K727R, K726RDeficiency of alpha-mannosidaseUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr19:12766637
GRCh38:
Chr19:12655823
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Jan 26, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr19:12774136
GRCh38:
Chr19:12663322
MAN2B1A302SDeficiency of alpha-mannosidaseUncertain significance
(Sep 1, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr19:12766635
GRCh38:
Chr19:12655821
MAN2B1A567G, A568GDeficiency of alpha-mannosidaseUncertain significance
(Aug 17, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr19:12759174
GRCh38:
Chr19:12648360
MAN2B1E826Q, E827QDeficiency of alpha-mannosidaseUncertain significance
(May 21, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr19:12776316
GRCh38:
Chr19:12665502
MAN2B1G96SDeficiency of alpha-mannosidaseUncertain significance
(Oct 28, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr19:12772176
GRCh38:
Chr19:12661362
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Sep 19, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr19:12774111
GRCh38:
Chr19:12663297
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Sep 26, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr19:12769069
GRCh38:
Chr19:12658255
MAN2B1R400H, R399HDeficiency of alpha-mannosidaseUncertain significance
(Jan 15, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr19:12760785
GRCh38:
Chr19:12649971
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Oct 12, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr19:12776172
GRCh38:
Chr19:12665358
MAN2B1R144CDeficiency of alpha-mannosidaseUncertain significance
(May 27, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr19:12777374
GRCh38:
Chr19:12666560
MAN2B1R48GDeficiency of alpha-mannosidaseUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr19:12757543
GRCh38:
Chr19:12646729
MAN2B1P975R, P976RDeficiency of alpha-mannosidaseUncertain significance
(May 22, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr19:12759027
GRCh38:
Chr19:12648213
MAN2B1G875S, G876SDeficiency of alpha-mannosidaseUncertain significance
(Oct 17, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr19:12766585
GRCh38:
Chr19:12655771
MAN2B1R585G, R584GDeficiency of alpha-mannosidaseUncertain significance
(May 25, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr19:12759035
GRCh38:
Chr19:12648221
MAN2B1P872L, P873LDeficiency of alpha-mannosidaseUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr19:12776359
GRCh38:
Chr19:12665545
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Nov 1, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr19:12758100
GRCh38:
Chr19:12647286
MAN2B1V957A, V956ADeficiency of alpha-mannosidase, Inborn genetic diseasesConflicting interpretations of pathogenicity
(May 31, 2022)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr19:12767829
GRCh38:
Chr19:12657015
MAN2B1K486N, K487NDeficiency of alpha-mannosidaseUncertain significance
(Jun 28, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr19:12767875
GRCh38:
Chr19:12657061
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Jun 4, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr19:12759226
GRCh38:
Chr19:12648412
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Aug 5, 2019)
criteria provided, single submitter
83.
GRCh37:
Chr19:12758421-12758440
GRCh38:
Chr19:12647607-12647626
MAN2B1Deficiency of alpha-mannosidaseUncertain significance
(Aug 12, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr19:12760142
GRCh38:
Chr19:12649328
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Aug 3, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr19:12767743
GRCh38:
Chr19:12656929
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Jul 26, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr19:12759175
GRCh38:
Chr19:12648361
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Jun 5, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr19:12760770
GRCh38:
Chr19:12649956
MAN2B1R742C, R741CDeficiency of alpha-mannosidaseUncertain significance
(Aug 26, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr19:12767779
GRCh38:
Chr19:12656965
MAN2B1S503T, S504TDeficiency of alpha-mannosidaseUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr19:12760231
GRCh38:
Chr19:12649417
MAN2B1R759P, R760PDeficiency of alpha-mannosidaseUncertain significance
(Aug 23, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr19:12776171
GRCh38:
Chr19:12665357
MAN2B1R144HDeficiency of alpha-mannosidaseUncertain significance
(Jan 26, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr19:12759048
GRCh38:
Chr19:12648234
MAN2B1V869M, V868MDeficiency of alpha-mannosidaseUncertain significance
(May 29, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr19:12769064
GRCh38:
Chr19:12658250
MAN2B1E401Q, E402QDeficiency of alpha-mannosidaseUncertain significance
(Jun 20, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr19:12774528
GRCh38:
Chr19:12663714
MAN2B1D251VDeficiency of alpha-mannosidaseUncertain significance
(Aug 5, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr19:12767475
GRCh38:
Chr19:12656661
MAN2B1Deficiency of alpha-mannosidaseUncertain significance
(Jul 26, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr19:12766712
GRCh38:
Chr19:12655898
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Oct 12, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr19:12760135
GRCh38:
Chr19:12649321
MAN2B1Deficiency of alpha-mannosidaseBenign
(Nov 1, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr19:12772203
GRCh38:
Chr19:12661389
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Sep 5, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr19:12769247
GRCh38:
Chr19:12658433
MAN2B1Deficiency of alpha-mannosidaseLikely benign
(Jan 12, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr19:12774622
GRCh38:
Chr19:12663808
MAN2B1R220CDeficiency of alpha-mannosidaseUncertain significance
(Apr 15, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr19:12776321
GRCh38:
Chr19:12665507
MAN2B1H94RDeficiency of alpha-mannosidaseUncertain significance
(Feb 13, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination